Отдел кадров или маркетинг?Получите бесплатную учетную запись работодателя
Pfizer Заявленная компания

Pfizer Культура компании

Рейтинг культуры

Этот рейтинг рассчитан на основе оценок и обзоров сотрудников
4.1/5
Pfizer's Общая культура Pfizer имеет рейтинг B

Топ культурных аспектов

Рейтинг CEO

Топ 20%Топ 20% компаний подобного размера на Comparably
Albert Bourla Pfizer's CEO
Albert Bourla
74 /100

Миссия, идея и ценности компании Pfizer

Понятны ли вам цели компании? Принимаете ли вы участие в их достижении?

Миссия

At Pfizer, we innovate every day to make the world a healthier place. It was the vision of Charles Pfizer at the very beginning and it holds true today in everything we do. From scientific discovery to breakthrough products to our essential partnerships around the world, we're committed to quality healthcare for everyone. Because every individual matters.

Концепция

Pfizer vision statement is Innovate to bring therapies to patients that significantly improve their lives.

Взгляд на культуру компании Pfizer

323 сотрудников Pfizer оценили свою компанию в различных культурных аспектах, высказав свое мнение по широкому спектру вопросов, начиная с оценки руководства и заканчивая темпом работы. Последний обзор 2 дней назад.

В целом, 323 сотрудников Pfizer оценивают лидерство в компании на B или Top 30% среди компаний подобного размера на Comparably. В это входит конкретные рейтинги их команды руководителей, генерального директора и менеджера.

Сотрудники Pfizer довольны компенсацией в Pfizer, которая включает в себя набор из заработной платы, доли компании и акции, а также бенефиты.

В целом, сотрудники Pfizer удовлетворены своей командой. 323 участников оценивают качество своих коллег на B. Большинство сотрудников верит, что совещания в Pfizer эффективны, и большинство из них ждут с нетерпением возможности пообщаться с коллегами.

Большинство сотрудников Pfizer верит, что рабочее окружение в Pfizer положительное. Большинство участников верят, что темп работы в Pfizer комфортно быстрый. Примерно 56% сотрудников Pfizer работают 8 часов или меньше, в то время как у 10% сотрудников экстремально длинный рабочий день - более 12 часов.

В целом, сотрудники Pfizer преимущественно счастливы, основываясь на совокупности оценок перспектив, восприятия клиентов и их энтузиазма в работе.

Информация о компании

Адрес
235 East 42nd Street
New York City, NY 10017
United States of America
Сайт
www.pfizer.com
Основана
1848

Описание компании

Pfizer, a bio-pharmaceutical company, develops and manufactures human and veterinary medicines, as well as consumer healthcare products.

Ключевые руководители

Имя, должность
Био
Albert Bourla  CEO / President
Albert Bourla
CEO / President
Albert Bourla serves as the CEO / President of Pfizer.
Mikael Dolsten M.D., Ph.D.  President of Worldwide Research & Development and Executive VP
Mikael Dolsten M.D., Ph.D.
President of Worldwide Research & Development and Executive VP
Dr. Mikael Dolsten, MD, Ph.D., has been the President of Worldwide Research and Development at Pfizer Inc. since December 2010 and has been its Executive VP since June 13, 2017. Dr. Dolsten serves as an Executive Vice President of Pfizer Inc. Dr. Dolsten also serves as a Member of Pfizer Executive Leadership Team. Dr. Dolsten serves as the President of Worldwide Research and Development at Pfizer Limited. Prior to joining Pfizer in 2009, he served as Senior Vice President of Wyeth and President of Wyeth Research, where he was responsible for the global R&D division and led scientists across the US, Europe and Asia. Before joining Wyeth, he served as an Executive Vice President at Boehringer Ingelheim, where he was responsible for worldwide research including activities at R&D sites in the US, Canada, Germany, Italy, Austria and Japan. He served as Head of Corporate Division Pharma Research/Discovery at Boehringer Ingelheim with responsible for approximately 1400 discovery scientists and world-wide research in respiratory, immunology/inflammation, metabolic disease, CNS/pain, oncology and cardiovascular therapies. Dr. Dolsten was a Partner at OrbiMed Advisors, L.L.C. He held various senior R&D management positions including: Head of Preclinical Research Oncology/Immunology at Pharmacia & Upjohn, Lund and Head of Preclinical R&D, Vice President of Respiratory and Inflammation at Astra Draco, Lund. In addition, he gained leadership experience from five large-scale M&A transactions. He served as the President of BioTherapeutics Research & Development at Pfizer Inc. from October 2009 to May 2010 and served as its Senior Vice President from May 2010 to December 2010. Prior to joining Boehringer Ingelheim in 2003, Dr. Dolsten was responsible for integrating several areas of AstraZeneca Discovery post-merger. He also served as Global Vice President/Head of Cardiovascular/Metabolic & Gastrointestinal Discovery at AstraZeneca. Dr. Dolsten has spent approximately seventeen years in the pharmaceutical Industry. He has been Chairman, Translational Advisory Board of Apple Tree Partners since 2016. Dr. Dolsten has been an Independent Director at Karyopharm Therapeutics Inc. since March 31, 2015. He serves as a Member of Translational Advisory Board at Apple Tree Partners. He serves as a Member of MDL Scientific Advisory Board at Elsevier B.V. He served as a Director of Receptos, Inc. He is a Member of the Biomedical Advisory Council of The Pharmaceutical Research and Manufacturers of America (PhRMA) and serves on the PhRMA Foundation Board of Directors. He has been a Board Member of a Swedish Business School for Innovation and Chamber of Commerce. He is a Governor of the New York Academy of Sciences. He was appointed as Adjunct Professor in Immunology at the Medical Faculty in Lund, Sweden. He was Associate Professor at Lund University since 1989 and Adjunct Professor in Cell and Molecular Biology since 1996. Dr. Dolsten is a named inventor on several patents and has published approximately 150 articles in international journals, with particular contributions in areas such as molecular cell biology, immunology and oncology. He earned his Ph.D. in Tumor Immunology and M.D. from the University of Lund in Sweden. He also studied Virology and Cell Biology at the Weizmann Institute in Israel.
John D. Young  Group President of Pfizer Innovative Health
John D. Young
Group President of Pfizer Innovative Health
Mr. John D. Young has been the Group President of Pfizer Innovative Health at Pfizer Inc. since January 1, 2018 and served as its Group President of Pfizer Essential Health from June 2016 to January 1, 2018. Mr. Young is a Director of Johnson Controls International plc from December 2017. He served as a Group President of Global Established Pharma Business at Pfizer Inc. from January 1, 2014 to June 2016. Mr. Young served as President and General Manager of Primary Care Business Unit at Pfizer Inc. from June 1, 2012 to December 2013 and U.K. Country Manager from 2007 until 2009. He served as Regional President of Europe and Canada for The Primary Care Business at Pfizer Inc. from 2009 to June 1, 2012. Over his 25-year career with Pfizer, he served a number of commercial positions with the company, including country and regional management roles in Australia/New Zealand and the United Kingdom. He is a scientist by training and has deep knowledge of the company's innovative biopharmaceutical portfolio having led the commercial and clinical development of medicines in key therapeutic areas including cardiovascular disease, diabetes and pain. Mr. Young received a BSc in Biological Science from Glasgow University and an MBA from Strathclyde Graduate Business School.
Frank A. D'Amelio  CFO & Executive VP of Business Operations
Frank A. D'Amelio
CFO & Executive VP of Business Operations
Frank A. D'Amelio has served as a Director of Humana Inc. since September 2003. He is Executive Vice President, Business Operations and Chief Financial Officer of Pfizer Inc., having held this position since December 2010, and having served as Chief Financial Officer since September 2007. Prior to that, Mr. D'Amelio was Senior Executive Vice President of Integration and Chief Administrative Officer at Alcatel-Lucent from December 2006 to August 2007, and Chief Operating Officer of Lucent Technologies Inc. from February 2006 to November 2006. From May 2001 until January 2006, he was Executive Vice President, Administration and Chief Financial Officer of Lucent. Mr. D'Amelio also serves on the Board of Directors of Zoetis, Inc. and on the board of the Independent College Fund of New Jersey.
Annette Doherty  Head of Worldwide Pharmaceutical Sciences
Annette Doherty
Head of Worldwide Pharmaceutical Sciences
Dr. Annette Doherty has been Head of Worldwide Pharmaceutical Sciences of Pfizer Inc., since May 2005.
Kathrin U. Jansen  Senior Vice President & Head of Vaccine Research & Development
Kathrin U. Jansen
Senior Vice President & Head of Vaccine Research & Development
Dr. Kathrin U. Jansen, Ph.D. has been Senior Vice President of Vaccine Research & Development at Pfizer Inc. since June 01, 2015. Dr. Jansen served as Senior Vice President of Early Phase Programs of Vaccine Research at Wyeth LLC. Dr. Jansen served as Senior Vice President of Research and Development and Chief Scientific Officer of VaxGen Inc., from October 19, 2004 to July 29, 2006. Dr. Jansen lead an organization of approximately 550 colleagues comprised of clinicians, vaccine process/analytical/and formulation development, and other laboratory scientists. Dr. Jansen joined VaxGen in October 2004 after having served as Executive Director of Microbial Vaccine Research for Merck Research Laboratories. At Vaxgen, Dr. Jansen leads a team of more than 40 scientists and related personnel in developing Vaxgen's existing investigational vaccines, as well as evaluating and developing new product candidates. Dr. Jansen was the scientific leader of the team that successfully developed Merck's Phase III human papillomavirus (HPV) vaccine candidate to prevent genital warts and cervical cancer. Additionally, she was responsible for several bacterial vaccine programs at Merck. Dr. Jansen also headed the clinical assay laboratory responsible for the development and validation of new assays and for the clinical testing of all existing Merck accines and vaccine candidates. Dr. Jansen joined Merck in 1992 as a research fellow and advanced through a series of positions with increasing responsibility. Prior to Merck, she served from 1989 to 1992 as a research scientist at the Glaxo Institute for Molecular Biology, where she studied the structure and function of a low affinity receptor for IgE (CD23). Prior to her career in industry, Dr. Jansen held research positions at Cornell University and Institut fur Mikrobiologie, Marburg, Germany. She is an author on 53 scientific articles and the inventor on seven issued patents and numerous patent applications related to vaccine research and development. She holds a Ph.D. in Microbiology, with a minor in Biochemistry and Genetics and an undergraduate degree in Biology from Philipps-Universitat, Marburg, Germany.
Hugh Donnelly  Chief Internal Auditor
Hugh Donnelly
Chief Internal Auditor
Mr. Hugh Donnelly serves as the Chief Internal Auditor of Pfizer Inc. and served as its Vice President of Corporate Audit. Mr. Donnelly assumed this position in July, 2002 and is responsible for leading 120 audit professionals primarily based in New York, New Jersey, Connecticut, Pennsylvania, Mumbai and Dublin. Corporate Audit provides independent, Pan-Pfizer corporate regulatory audit and oversight of processes and systems spanning its operating model including: discovery, development, manufacturing, commercial sales & marketing activities, finance and information technology. Previously, he was Assistant Controller, Pfizer Inc. with responsibility for Pfizer's Financial Shared Services. He served US Treasury operations and European finance roles in Corporate Treasury. Hugh joined Pfizer as Controller of the acquired SmithKline Beecham Animal Health business in 1995. Hugh has held numerous other financial positions in commercial operations, manufacturing and corporate finance over a 25+ year career in the pharmaceutical industry. Hugh is CPA who started his career with PriceWaterhouse Coopers/Coopers & Lybrand. He holds a BS in Accounting from Villanova University.
Susan Silbermann  President of Global Vaccines Business and General Manager of Global Vaccines Business
Susan Silbermann
President of Global Vaccines Business and General Manager of Global Vaccines Business
Susan Silbermann has been President of Global Vaccines Business and General Manager of Global Vaccines Business at Pfizer Inc., since January 1, 2014. Susan Silbermann serves as the Regional President, Latin America at Emerging Markets Business Unit of Pfizer Inc. Susan Silbermann serves as a Member of the Advisory Board at Catalyst Inc.
Loretta V. Cangialosi  Senior Vice President and Controller
Loretta V. Cangialosi
Senior Vice President and Controller
Ms. Loretta V. Cangialosi has been a Senior Vice President and Controller of Pfizer, Inc since February 1993 and served as its Vice President. Ms. Cangialosi serves as a Member of Standing Advisory Group at Public Company Accounting Oversight Board (PCAOB).
Michael Vincent M.D., Ph.D.  Chief Scientific Officer of Inflammation & Immunology Research Unit and Senior Vice President
Michael Vincent M.D., Ph.D.
Chief Scientific Officer of Inflammation & Immunology Research Unit and Senior Vice President
Dr. Michael Vincent, M.D., Ph.D. has been Senior Vice President and Chief Scientific Officer of Inflammation and Immunology Research Unit at Pfizer Inc. since May 2016. Since joining Pfizer in 2011, Dr. Vincent served numerous scientific leadership roles, served as Clinical Head for Pharmatherapeutics and Biotherapeutics. Before joining Pfizer, Dr. Vincent served several positions within Medical Sciences at Amgen. He also served as a staff physician at Harvard University. Dr. Vincent earned his Ph.D. and M.D. degrees from Indiana University. He completed his residency and began his post-doctoral training at the University of Vermont and ultimately completed at Harvard University.

Лидеры отдела кадров

Имя, должность
Био
Pamela Puryear  Senior Vice President, Chief Talent Officer
Pamela Puryear
Senior Vice President, Chief Talent Officer
Pamela Puryear serves as the Senior Vice President, Chief Talent Officer of .
Barbara Elsden  VP Human Resources
Barbara Elsden
VP Human Resources
Barbara Elsden serves as the VP Human Resources of .
Kristin Papesh  Vice President, Human Resources
Kristin Papesh
Vice President, Human Resources
Kristin Papesh serves as the Vice President, Human Resources of .
Hong Lu  Vice President, Global HR Operations
Hong Lu
Vice President, Global HR Operations
Hong Lu serves as the Vice President, Global HR Operations of .
Rachel Cheeks-Givan  Global Director Diversity & Inclusion
Rachel Cheeks-Givan
Global Director Diversity & Inclusion
Rachel Cheeks-Givan serves as the Global Director Diversity & Inclusion of .
Steven Burdette  Director, Diversity & Inclusion
Steven Burdette
Director, Diversity & Inclusion
Steven Burdette serves as the Director, Diversity & Inclusion of .
Dan Miller  Director, HR Business Technology (Global Operations and M&A Lead)
Dan Miller
Director, HR Business Technology (Global Operations and M&A Lead)
Dan Miller serves as the Director, HR Business Technology (Global Operations and M&A Lead) of .
Kim Robbins  Director, Culture and Employee Engagement
Kim Robbins
Director, Culture and Employee Engagement
Kim Robbins serves as the Director, Culture and Employee Engagement of .
Gaurav Jain  Director Global HR Reporting, Analytics & Security
Gaurav Jain
Director Global HR Reporting, Analytics & Security
Gaurav Jain serves as the Director Global HR Reporting, Analytics & Security of .
Janice Beauchamp  VP, Human Resources - Medical, Corporate Strategy and HR Business Development
Janice Beauchamp
VP, Human Resources - Medical, Corporate Strategy and HR Business Development
Janice Beauchamp serves as the VP, Human Resources - Medical, Corporate Strategy and HR Business Development of .
Catherine Dimes  Vice President, Global Talent Acquisition
Catherine Dimes
Vice President, Global Talent Acquisition
Catherine Dimes serves as the Vice President, Global Talent Acquisition of .
Elaine Cunningham  Sr. Director, Human Resources HR Lead
Elaine Cunningham
Sr. Director, Human Resources HR Lead
Elaine Cunningham serves as the Sr. Director, Human Resources HR Lead of .
Thomas Kirchgasser  Vice President Human Resources - Pfizer Global Supply ( Manufacturing)
Thomas Kirchgasser
Vice President Human Resources - Pfizer Global Supply ( Manufacturing)
Thomas Kirchgasser serves as the Vice President Human Resources - Pfizer Global Supply ( Manufacturing) of .
Denny Glasper  Director - Human Resources
Denny Glasper
Director - Human Resources
Denny Glasper serves as the Director - Human Resources of .
Michael OConnor  Director, HR Global Operations, Vendor Management
Michael OConnor
Director, HR Global Operations, Vendor Management
Michael OConnor serves as the Director, HR Global Operations, Vendor Management of .
Bob Matts  VP, HR, Business Platforms
Bob Matts
VP, HR, Business Platforms
Bob Matts serves as the VP, HR, Business Platforms of .
Scott White  Director Human Resources
Scott White
Director Human Resources
Scott White serves as the Director Human Resources of .
Neena Dosanj  Senior Director, Pfizer Consumer Healthcare Human Resources Lead
Neena Dosanj
Senior Director, Pfizer Consumer Healthcare Human Resources Lead
Neena Dosanj serves as the Senior Director, Pfizer Consumer Healthcare Human Resources Lead of .
Sander Beer  Vice President Human Resources - Worldwide R&D
Sander Beer
Vice President Human Resources - Worldwide R&D
Sander Beer serves as the Vice President Human Resources - Worldwide R&D of .
Jennifer Bartell  Director, HR Global Operations
Jennifer Bartell
Director, HR Global Operations
Jennifer Bartell serves as the Director, HR Global Operations of .
Lucille Askes  Manager, North America Talent Acquisition, Global Science
Lucille Askes
Manager, North America Talent Acquisition, Global Science
Lucille Askes serves as the Manager, North America Talent Acquisition, Global Science of .
Dana Allison  Director, Human Resources
Dana Allison
Director, Human Resources
Dana Allison serves as the Director, Human Resources of .
Lisa Marin  Senior Director, Human Resources - Pfizer Essential Health, North America
Lisa Marin
Senior Director, Human Resources - Pfizer Essential Health, North America
Lisa Marin serves as the Senior Director, Human Resources - Pfizer Essential Health, North America of .
Erin Clark  Director, Human Resources
Erin Clark
Director, Human Resources
Erin Clark serves as the Director, Human Resources of .
Flor Battilana  Sr. Director Human Resources - Executive Operations
Flor Battilana
Sr. Director Human Resources - Executive Operations
Flor Battilana serves as the Sr. Director Human Resources - Executive Operations of .
Jackie Goldschmidt  Director, Global Talent Acquisition - Pfizer Global Supply (PGS)
Jackie Goldschmidt
Director, Global Talent Acquisition - Pfizer Global Supply (PGS)
Jackie Goldschmidt serves as the Director, Global Talent Acquisition - Pfizer Global Supply (PGS) of .
Darren DeLuca  Manager, US Recruitment Outreach (Veterans & People with Disabilities)
Darren DeLuca
Manager, US Recruitment Outreach (Veterans & People with Disabilities)
Darren DeLuca serves as the Manager, US Recruitment Outreach (Veterans & People with Disabilities) of .
Tania ODonnell  Senior Leader, Global Talent Acquisition- Worldwide Research & Development
Tania ODonnell
Senior Leader, Global Talent Acquisition- Worldwide Research & Development
Tania ODonnell serves as the Senior Leader, Global Talent Acquisition- Worldwide Research & Development of .
Amora Carlotta  Human Resources Director
Amora Carlotta
Human Resources Director
Amora Carlotta serves as the Human Resources Director of .
Nila Nath  Senior Talent Acquisition Specialist - Pfizer Global Supply
Nila Nath
Senior Talent Acquisition Specialist - Pfizer Global Supply
Nila Nath serves as the Senior Talent Acquisition Specialist - Pfizer Global Supply of .

Pfizer Oтзывы от сотрудников

Положительные отзывы
69%
69%
31%
Конструктивные отзывы
31%

Положительные отзывы от сотрудников

Что вам понравилось больше всего в процессе собеседования?

Behavioral and leadership questions, scenario based, less technical

Что приносит вам больше всего счастья/радости на работе?

Flexible, less stress, happiness, joyous

Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?

Friendly, great atmosphere, joyous, innovative, interesting

Конструктивные отзывы от сотрудников

Почему вы чувствуете себя недооцененным(ой), и как ваша зарплата могла бы на это повлиять?

Atleast 10percent increase than my current pay

getting more the share of the profits

В чем руководство должно стать лучше?

Paying attention and listening to their SMEs

День из жизни
День из жизни
Сотрудники Pfizer обычно работают 9.3 часов в день
Рабочие часы
День из жизни
Сотрудники Pfizer оценивают темп работы как комфортно быстрый
Темп работы
День из жизни
В обычный день сотрудники Pfizer проводят 2 совещаний
Встречи
День из жизни
82% сотрудников Pfizer с нетерпением ждут встречи со своей командой каждый день
Коллеги
День из жизни
Сотрудники Pfizer чаще всего берут 20-30 дней оплаченного отпуска и больничного в год
Преимущества и бенефиты
День из жизни
62% сотрудников Pfizer говорят, что они довольны балансом работы и личной жизни
Баланс работы и личной жизни
День из жизни
Сотрудники Pfizer обычно получают ценные отзывы о том, как улучшить работу на работе, раз в квартал
Обратная связь
День из жизни
74% сотрудников Pfizer называют рабочее окружение в позитивной
Окружение

Дайте Pfizer знать, что вы там работаете

Рассказать Pfizer о своем интересе к работе в компании, сохраняя анонимность. Comparably предоставит Pfizer возможность нанять вас. Как только появится подходящая вакансия -- мы сделаем так, чтобы вы нашли друг друга.

Хотите узнать, каково работать в Pfizer?

Анонимно задайте сотрудникам Pfizer любой вопрос

Задать анонимный вопрос

Анонимные вопросы и ответы с сотрудниками Pfizer

Недавние вопросы и ответы

Топ
30%

Рейтинг по лидерству

Входит в Топ 30% компаний подобного размера на Comparably

Позитивная тенденцияРейтинг в этой категории вырос на % за последний месяц
69
из 100
Оценка исполнения?
74
из 100
Оценка СЕО?
71
из 100
Оценка менеджеру?
Топ
20%

Рейтинг по компенсации

Входит в Топ 20% компаний подобного размера на Comparably

Позитивная тенденцияРейтинг в этой категории вырос на % за последний месяц
Достойная зарплата?
Довольны бенефитами?
Топ
35%

Рейтинг команды

Входит в Топ 35% компаний подобного размера на Comparably

Позитивная тенденцияРейтинг в этой категории вырос на % за последний месяц
Взаимодействие с сотрудниками?
76
из 100
Качество коллег?
Топ
40%

Рейтинг окружения

Входит в Топ 40% компаний подобного размера на Comparably

Позитивная тенденцияРейтинг в этой категории вырос на % за последний месяц
7 или менее
8%
8
48%
10
27%
12
7%
Более 12
10%
Часы работы?
Очень быстрый
24%
Комфортно быстрый
40%
Средний
24%
Замедленный
5%
Бюрократичный
7%
Рабочий темп?
В позитивной
74%
В негативной
26%
Позитивная атмосфера?
Топ
30%

Рейтинг перспектив

Входит в Топ 30% компаний подобного размера на Comparably

Позитивная тенденцияРейтинг в этой категории вырос на % за последний месяц
78
из 100
Перспективное будущее?
Отлично
20%
Хорошо
46%
Нейтрально
22%
Плохо
10%
Ужасно
2%
Мнение клиента?
Работа в удовольствие?

Pfizer Виза H1B

В 2019 году, компания Pfizer подала на 82 H1B виз. Из поданных заявок на разрешение на работу, 74% были одобрены.

Решение по заявке о разрешении на работу

82
Всего подали заявок
  • 74% Одобрено (61 из 82)
  • 2% Отказано (2 из 82)
  • 0% Отозвали заявки Работодатель отменил заявку до принятия решения ( из 82)
  • 23% Подтвержденные отозванные Заявка была принята, но затем отозвана работодателем (19 из 82)

Эти данные были рассчитаны с использованием общедоступных по данных из отчета OFLC о производительности

Рейтинг по полу Насколько положительно женщины оценивают свой опыт работы в Pfizer

Топ
50%

Pfizer входит в Топ 50% компаний подобного размера на Comparably

Рейтинг по разнородности Насколько положительно меньшинства оценивают свой опыт работы в Pfizer

Топ
50%

Pfizer входит в Топ 50% компаний подобного размера на Comparably

eNPS

Чистый индекс поддержки выводится на основе ответов ваших сотрудников на вопрос "По шкале от 1 до 10, насколько вероятно, что вы порекомендуете друзьям работу в своей компании?"
Топ 25%Топ 25% компаний подобного размера на Comparably
22
Индекс eNPS
49%Promoters
24%Passives
27%Detractors

Видео о культуре в Pfizer

Посмотреть все СМИ

Видео конкурентов Pfizer

Конкуренты Pfizer

  1. 1st
    Johnson & Johnson
    76 / 100
  2. 2nd
    AbbVie
    76 / 100
  3. 3rd
    Roche
    75 / 100
  4. 4th
    Merck
    74 / 100
  5. 5th
    Pfizer
    72 / 100

Преимущества и бенефиты

Здоровье и Благополучие
Стоматологическое страхование
Страхование Зрения
Страхование Здоровья

Знаете кого-то, кто работает в Pfizer?

Отправьте им приглашение, чтобы оценить культуру внутри компании.

Отправить анонимное приглашение

×
Оцените свою компанию